| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/08/2009 | US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 01/08/2009 | US20090010919 Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap) |
| 01/08/2009 | US20090010909 Novel GPCR and methods of use of the same |
| 01/08/2009 | US20090010908 Materials and Methods for Diagnosis and Treatment of Chronic Fatigue Syndrome |
| 01/08/2009 | US20090010896 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| 01/08/2009 | US20090010888 Use of cytochrome P450 reductase as insecticidal target |
| 01/08/2009 | US20090010885 Methods for Detecting and Treating Autoimmune Disorders |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010808 Bio-sensor and bio-sensor reporting system |
| 01/08/2009 | US20090008248 Enzyme Electrode and Enzyme Sensor |
| 01/08/2009 | DE102007031947A1 Allergene aus Aspergillus versicolor und Verfahren zum Nachweis einer innenraumbedingten Schimmelpilzallergie Allergens from Aspergillus versicolor and method for detecting an interior mold allergy-related |
| 01/08/2009 | DE102007031574A1 Minor-Spleißosom Testsystem zur Modulierung der Zellteilung Minor spliceosome test system for modulating cell division |
| 01/08/2009 | DE102007017681A1 Device for determining activity of enzymes in liquid test sample containing enzyme and enzyme inhibitor, comprises chromatography column, which contains substrate and substance bound to substrate |
| 01/08/2009 | DE102006054292A1 Verwendung von Genveränderungen im menschlichen Gen CHK1, das für die Checkpointkinase 1 kodiert Use of gene mutations in the human gene CHK1, which encodes the checkpoint kinase 1 |
| 01/08/2009 | CA2722015A1 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | CA2707436A1 Copy dna and sense rna |
| 01/08/2009 | CA2692478A1 Treatment of influenza |
| 01/08/2009 | CA2692457A1 Treatment of cardiovascular disease with salicylates |
| 01/08/2009 | CA2692186A1 Methods for extraction and purification of components of biological samples |
| 01/08/2009 | CA2691964A1 Androgen-dependent 1-f-aromatase reporter gene |
| 01/08/2009 | CA2691942A1 Chimeric primers for improved nucleic acid amplification reactions |
| 01/08/2009 | CA2691940A1 Methods for providing improved immunoglobulin sequences |
| 01/08/2009 | CA2691677A1 Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof |
| 01/08/2009 | CA2691647A1 High multiplex nucleic acid amplification |
| 01/08/2009 | CA2691427A1 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| 01/08/2009 | CA2691267A1 Use of mdck cells in the evaluation of cholesterol modulators |
| 01/08/2009 | CA2690593A1 Tace inhibitors in the treatment of acne |
| 01/08/2009 | CA2690481A1 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones |
| 01/08/2009 | CA2689389A1 System and method for adaptive reagent control in nucleic acid sequencing |
| 01/07/2009 | EP2012125A1 Molecular modification assays |
| 01/07/2009 | EP2012124A2 Method for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 01/07/2009 | EP2012116A1 Individual discrimination method and apparatus |
| 01/07/2009 | EP2011889A1 Methods for measuring drug resistance against HCV |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011887A2 Method for differentiating between the non-infectious and infectious causes of multiple organ failure |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011885A2 Method of diagnosing bladder cancer |
| 01/07/2009 | EP2011884A1 DNA diagnostics based on mass spectrometry |
| 01/07/2009 | EP2011883A1 Method of predicting skin spot formation and method of screening skin spot formation inhibitor with the use of spot site-increasing genes as indication |
| 01/07/2009 | EP2011882A1 Method for screening of substance capable of increasing glutathione |
| 01/07/2009 | EP2011881A1 Androgen-dependent gene fusion comprising the 1f aromatase promoter and a reporter gene |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011872A1 Instrument and method for nucleic acid isolation |
| 01/07/2009 | EP2011871A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe |
| 01/07/2009 | EP2011868A1 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine |
| 01/07/2009 | EP2011511A2 Pharmaceutical composition containing the nmb0938 protein |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011503A2 High affinity nucleic acid ligands of cytokines |
| 01/07/2009 | EP2011068A2 Methylation of genes as a predictor of polyp formation and recurrence |
| 01/07/2009 | EP2010922A1 Methods and kit for endometriosis screening |
| 01/07/2009 | EP2010913A1 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events |
| 01/07/2009 | EP2010911A2 Treatment of tumors expressing mutant egf receptors |
| 01/07/2009 | EP2010680A2 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/07/2009 | EP2010679A2 Compositions for the use in identification of fungi |
| 01/07/2009 | EP2010678A2 Repair of nucleic acids for improved amplification |
| 01/07/2009 | EP2010677A2 Methods and compositions for detecting polynucleotides |
| 01/07/2009 | EP2010676A1 Method and kit for molecular chromosomal quantification |
| 01/07/2009 | EP2010675A2 New detector probe acting by molecular recognition |
| 01/07/2009 | EP2010674A1 A sex-specific marker for shrimps and prawns |
| 01/07/2009 | EP2010673A2 Means and methods for diagnosing and treating cancer based on the frmd3 gene |
| 01/07/2009 | EP2010672A1 Formulations and method for isolating nucleic acids from complex starting materials and subsequent complex genetic analysis |
| 01/07/2009 | EP2010671A1 Detection and quantification of faecal pollution in an environmental sample |
| 01/07/2009 | EP2010670A1 Method for amplifying unknown dna sequence adjacent to known sequence |
| 01/07/2009 | EP2010669A1 Method for determining the activity of a protease in a sample |
| 01/07/2009 | EP2010668A2 Systems and methods for efficient collection of single cells and colonies of cells and fast generation of stable transfectants |
| 01/07/2009 | EP2010667A2 Displaying cellular analysis result data using surface elevation points |
| 01/07/2009 | EP2010656A2 Intracellular method for selecting a peptide or polypeptide which binds to a bait peptide or polypeptide |
| 01/07/2009 | EP2010554A2 Mig-7 as a specific anticancer target |
| 01/07/2009 | EP2010321A2 Assay device and method |
| 01/07/2009 | EP2010225A2 Methods and compositions for targeting c-rel |
| 01/07/2009 | EP2010224A2 Method and composition for treating and preventing tumor metastasis in vivo |
| 01/07/2009 | EP1910552A4 Methods and compositions for modulating cox |
| 01/07/2009 | EP1888089A4 Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements |
| 01/07/2009 | EP1799860A4 Dna fingerprinting using a branch migration assay |
| 01/07/2009 | EP1794173A4 Amplification blocker comprising intercalating nucleic acids (tna) containing intercalating pseudonucleotides (ipn) |
| 01/07/2009 | EP1791981A4 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis |
| 01/07/2009 | EP1786927B1 Device and method for the detection of charged macromolecules |
| 01/07/2009 | EP1776472A4 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics |
| 01/07/2009 | EP1692165B1 High throughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| 01/07/2009 | EP1675947B1 A method of screening for protein secreting recombinant host cells |
| 01/07/2009 | EP1660676B1 Diagnosis of risk of breast cancer |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1597397B1 Dna sequence analysis |
| 01/07/2009 | EP1578763B1 Process for purification of plasmid dna |
| 01/07/2009 | EP1572893B1 Production of adeno-associated virus in insect cells |
| 01/07/2009 | EP1563091B1 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 01/07/2009 | EP1540006B1 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
| 01/07/2009 | EP1536827B1 Use of protein kinase n beta |
| 01/07/2009 | EP1532239B1 Methods and compositions for targeting secretory lysosomes |
| 01/07/2009 | EP1515143B1 Method of assay by oxidation-reduction reaction with formazan |
| 01/07/2009 | EP1504030B1 Constitutively translocating cell line |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1442045B1 Isolation and purification of nucleic acids |
| 01/07/2009 | EP1440311B1 Affinity-shifted probes for quantifying analyte polynucleotides |
| 01/07/2009 | EP1436756B1 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 01/07/2009 | EP1425297B1 Isolation of neural stem cells using gangliosides and other surface markers |
| 01/07/2009 | EP1407046B1 Method of dna sequencing using cleavable tags |
| 01/07/2009 | EP1356292B1 Marker for antidepressant therapy and methods related thereto |
| 01/07/2009 | EP1311705B1 Sequencing method |
| 01/07/2009 | EP1307538B1 Detection of cox-2 activity and anandamide metabolites |